Form D · Biotechnology
Insight Genetics, Inc.
Nashville, TN · CIK 0001623645
Offering snapshot reported Nov 6, 2015 · SEC filing
- Reported sold
- $3.05M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $300K Reported outside-investor minimum
- First sale
- Oct 7, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 6, 2015 | Initial | $3,050,000 | No comparison | 1 | SEC filing |
| Oct 29, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-250846
Minimum offering amount of $3,000,000 up to maximum offering amount of $5,000,000.
Source: Form D, filed Nov 6, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronnie Andrews | Director |
| Christopher T. Callaghan | Director, Executive |
| Paul A. Dahlhauser | Director |
| Eric B. Dahlhauser | Director, Executive |
| David Hout | Executive |
| Richard Isaacson | Director |
| Stephan Morris | Executive |
| Rob Seitz | Executive |
| Richard Watts | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 International Plaza Drive Suite 510
Nashville, TN, 37217
Nashville, TN, 37217